Cover Image

Efficacy of Oral Nicorandil to Prevent Contrast-Induced Nephropathy in Patients with Chronic Renal Dysfunction Undergoing an Elective Coronary Procedure

Objectives: This prospective, randomized study was to investigate the role of nicorandil in the prevention of contrast-induced nephropathy (CIN) in patients with chronic renal dysfunction undergoing an elective coronary procedure. Methods: A total of 252 eligible patients were enrolled in this study...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zeyuan Fan (Author), Yang Li (Author), Hanhua Ji (Author), Xinwen Jian (Author)
Format:	Book
Published:	Karger Publishers, 2019-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
by: Ye Z, et al.
Published: (2018)

Nomogram Model to Predict Cardiorenal Syndrome Type 1 in Patients with Acute Heart Failure
by: Zeyuan Fan, et al.
Published: (2018)

Investigating the prevalence of contrast-associated nephropathy and the related risk factors in patients undergoing elective angioplasty
by: Mehrnoush Dianatkhah, et al.
Published: (2023)

Omega-3 Supplementation in the Prevention of Contrast Induced Nephropathy in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial
by: Farzaneh Foroughinia, et al.
Published: (2019)

Protective Effect of Nicorandil on Contrast-Induced Acute Kidney Injury After Emergency Percutaneous Coronary Intervention
by: Zuo-zhong Yu PhD, et al.
Published: (2023)

The Effects of Pentoxifylline on Contrast-induced Nephropathy Reduction in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Rouzbahani, et al.
Published: (2022)

The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease
by: G. N. Soboleva, et al.
Published: (2020)

The role of probucol preventing contrast-induced nephropathy in patients undergoing invasive coronary procedures - Systematic review and meta-analysis of randomized controlled trials
by: Raymond Pranata, et al.
Published: (2021)

Antithrombin Ⅲ is a Novel Predictor for Contrast Induced Nephropathy After Coronary Angiography
by: Rui Wu, et al.
Published: (2018)

Remote Ischemic Preconditioning Reduces the Risk of Contrast-Induced Nephropathy in Patients with Moderate Renal Impairment Undergoing Percutaneous Coronary Angiography: A Meta-Analysis
by: Jin Deng, et al.
Published: (2020)

Predictors of contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
by: Mohamed Abdel-Ghany, et al.
Published: (2021)

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention
by: Lucia Barbieri, et al.
Published: (2022)

Evaluation of renal microperfusion in hyperuricemic nephropathy by contrast-enhanced ultrasound imaging
by: Li He, et al.
Published: (2022)

The Association between Dapagliflozin Use and the Risk of Post-Contrast Acute Kidney Injury in Patients with Type 2 Diabetes and Chronic Kidney Disease: A Propensity-Matched Analysis
by: Tao Liu, et al.
Published: (2023)

Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
by: Mohamed Khalfallah, et al.
Published: (2021)

Effectiveness of edaravone in preventing contrast‐induced nephropathy in high‐risk patients undergoing coronary angiography: A randomized, double‐blind trial
by: Azam Esmailnejad, et al.
Published: (2024)

Remote Ischemic Preconditioning and Contrast-Induced Acute Kidney Injury in Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial
by: Karolina Stokfisz, MD, et al.
Published: (2020)

Preoperative fasting time in children undergoing elective surgical procedures
by: Larissa Silva Bergantini, et al.
Published: (2021)

Contrast-Induced Nephropathy in patients submitted to percutaneous coronary intervention: an integrative review
by: Matheus Santos Moitinho, et al.

Predictive Value of Systemic Inflammation Score for Contrast-Associated Acute Kidney Injury and Adverse Outcomes Among Patients Undergoing Elective Percutaneous Coronary Intervention
by: Zeng JL, et al.
Published: (2023)

Predictors of Non-Obstructive Coronary Artery Disease in Patients Undergoing Elective Coronary Angiography
by: Ghazal Peerwani, et al.
Published: (2023)

Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT
by: Heejung Choi, et al.
Published: (2012)

Current approach to contrast nephropathy
by: Hüsnü Değirmenci, et al.
Published: (2020)

Obesity is not associated with contrast nephropathy
by: Navin Jaipaul, et al.
Published: (2010)

Editorial: Contrast-induced nephropathy
by: Sinan Aydoğdu
Published: (2013)

Paclitaxel-Induced Endothelial Dysfunction in Living Rats Is Prevented by Nicorandil via Reduction of Oxidative Stress
by: Ken-ichi Serizawa, et al.
Published: (2012)

Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formation
by: Ken Aizawa, et al.
Published: (2015)

Contrast Induced Nephropathy - A Review
by: Rajul Rastogi, et al.
Published: (2017)

Contrast Induced Nephropathy in ICU settings
by: Raghavendra Vanaki
Published: (2018)

Contrast induced nephropathy; recent findings
by: Mardani Saeed, et al.
Published: (2013)

Contrast induced nephropathy by interventionist cardiology
by: Dra. Xiomara Castelo Villalón, et al.
Published: (2017)

Contrast-induced nephropathy - prevention and treatment
by: Mateusz Bajak, et al.
Published: (2024)

Acute coronary syndrome and renal dysfunction
by: F. I. Belyalov
Published: (2016)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015)

IS THE SYNTAX SCORE SUFFICIENT TO ASSESS THE RISK FOR PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTIONS?
by: E. S. Novikova, et al.
Published: (2017)

Effect of Perioperative Nicorandil on Myocardial Protection in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass, a Retrospective Study
by: Chen Y, et al.
Published: (2024)

Contrast-induced nephropathy; A literature review
by: Jafar Golshahi, et al.
Published: (2014)

Role of KIM-1 in early diagnosis of contrast-induced nephropathy following invasive cardiac procedure: A systematic review
by: Mantasha Shuaib, et al.
Published: (2024)

Design and evaluation of nicorandil extended-release tablet
by: Ju-Young Kim, et al.
Published: (2015)